Daniel J. Brennan, EVP and CFO at BOSTON SCIENTIFIC CORP (BSX), sold 224,150 shares at $75.91 ($16.9M) on 2024-05-22, disclosed to the SEC on 2024-05-23.
Scheduled sale ($16.9M) by EVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.91 | 64,454 | $4.9M | 28.9% |
| 2 | $75.91 | 64,454 | $4.9M | 28.9% |
| 3 | $75.11 | 47,621 | $3.6M | 21.1% |
| 4 | $75.11 | 47,621 | $3.6M | 21.1% |
| Total | $75.57 avg | 224,150 | $16.9M | 100% |
| Filing → |
| BSX | SELL | 2025-01-03 | $1.7M | — | Filing → |
| BSX | SELL | 2024-02-20 | $1.8M | — | Filing → |
| BSX | SELL | 2023-03-02 | $8.5M | — | Filing → |